| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,872 |
3,214 |
$140K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,073 |
5,004 |
$137K |
| 99215 |
Prolong outpt/office vis |
737 |
643 |
$43K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,139 |
979 |
$13K |
| 82947 |
|
2,919 |
2,343 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
836 |
753 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
157 |
128 |
$4K |
| 99423 |
|
55 |
29 |
$2K |
| 3044F |
|
834 |
713 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
376 |
343 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
75 |
68 |
$2K |
| 0513F |
|
107 |
102 |
$2K |
| 99406 |
|
171 |
135 |
$1K |
| 90756 |
|
70 |
65 |
$1K |
| 81002 |
|
505 |
451 |
$651.38 |
| 99497 |
|
42 |
32 |
$624.75 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
92 |
87 |
$614.60 |
| 82044 |
|
159 |
143 |
$590.99 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
362 |
330 |
$570.65 |
| 81003 |
|
360 |
321 |
$527.91 |
| 99000 |
|
52 |
47 |
$486.00 |
| 82570 |
|
130 |
118 |
$413.25 |
| 90686 |
|
46 |
34 |
$268.95 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
51 |
51 |
$222.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
481 |
439 |
$168.77 |
| 95923 |
|
12 |
12 |
$161.52 |
| 3046F |
|
105 |
86 |
$160.00 |
| 93000 |
|
16 |
13 |
$131.02 |
| 95924 |
|
12 |
12 |
$74.40 |
| 99454 |
|
62 |
60 |
$60.19 |
| 81000 |
|
24 |
19 |
$54.08 |
| 93922 |
|
24 |
12 |
$51.48 |
| 93040 |
|
12 |
12 |
$5.28 |
| 3078F |
|
2,795 |
2,307 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
3,559 |
2,813 |
$0.00 |
| 3077F |
|
1,173 |
993 |
$0.00 |
| 1160F |
|
4,638 |
3,615 |
$0.00 |
| 3288F |
|
153 |
112 |
$0.00 |
| 1159F |
|
4,640 |
3,621 |
$0.00 |
| 3725F |
|
198 |
128 |
$0.00 |
| 3051F |
|
21 |
14 |
$0.00 |
| 1090F |
|
137 |
97 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
171 |
119 |
$0.00 |
| 0521F |
|
29 |
21 |
$0.00 |
| 3075F |
|
1,012 |
927 |
$0.00 |
| 3079F |
|
1,969 |
1,718 |
$0.00 |
| 3080F |
|
584 |
518 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,025 |
861 |
$0.00 |
| 4000F |
|
527 |
439 |
$0.00 |
| 3074F |
|
3,181 |
2,612 |
$0.00 |
| 1034F |
|
818 |
659 |
$0.00 |
| 1170F |
|
146 |
113 |
$0.00 |
| 3008F |
|
2,655 |
2,093 |
$0.00 |
| 1036F |
|
2,501 |
1,959 |
$0.00 |
| 3061F |
|
115 |
97 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
376 |
298 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
116 |
58 |
$0.00 |
| 1125F |
|
69 |
47 |
$0.00 |
| 99458 |
|
13 |
12 |
$0.00 |
| 99457 |
|
57 |
39 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
79 |
56 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
34 |
29 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
31 |
23 |
$0.00 |
| 3072F |
|
14 |
12 |
$0.00 |